Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.9M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$23.4M |
| 4 |
Bilibili
BILI
|
+$21.7M |
| 5 |
Gaotu Techedu
GOTU
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$89.7M |
| 2 |
Dominion Energy
D
|
+$69.9M |
| 3 |
Cheniere Energy
LNG
|
+$63.1M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$62.8M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 15.11% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Healthcare | 12.79% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Amkor Technology
AMKR
$11.9B
| $249K | 0.02% |
+32,000
| New | +$348K |
|
827
Mercury Insurance
MCY
$5.89B
| $248K | 0.02% |
6,100
-3,124
| -34% | -$143K |
|
828
PetMed Express
PETS
$37.9M
| $248K | 0.02% |
8,600
-5,700
| -40% | -$149K |
|
829
Parker-Hannifin
PH
$128B
| $248K | 0.02% |
+1,908
| New | +$345K |
|
830
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| $248K | 0.02% |
+964
| New | +$294K |
|
831
Bruker
BRKR
$8.68B
| $247K | 0.02% |
+6,900
| New | +$320K |
|
832
Lamb Weston
LW
$7.53B
| $246K | 0.02% |
+4,300
| New | +$353K |
|
833
Orion
OEC
$340M
| $246K | 0.02% |
+33,000
| New | +$478K |
|
|
XRN
834
Chiron Real Estate Inc
XRN
$494M
| $245K | 0.02% |
+4,836
| New | +$325K |
|
835
Gentex
GNTX
$4.97B
| $244K | 0.02% |
11,000
+3,618
| +49% | +$100K |
|
|
NBP
836
NovaBridge Biosciences American Depositary Shares
NBP
$219M
| $244K | 0.02% |
+18,735
| New | +$234K |
|
|
XENT
837
DELISTED
Intersect ENT, Inc
XENT
| $244K | 0.02% |
20,617
-5,870
| -22% | -$130K |
|
838
Carpenter Technology
CRS
$23.6B
| $243K | 0.02% |
+12,454
| New | +$465K |
|
839
Perdoceo Education
PRDO
$2.07B
| $242K | 0.02% |
+22,400
| New | +$348K |
|
840
LendingTree
TREE
$435M
| $241K | 0.02% |
1,316
+482
| +58% | +$136K |
|
841
Zumiez
ZUMZ
$312M
| $241K | 0.02% |
+13,900
| New | +$392K |
|
842
Itron
ITRI
$4.32B
| $240K | 0.02% |
+4,300
| New | +$327K |
|
|
SVC
843
Service Properties Trust
SVC
$1.04B
| $240K | 0.02% |
+8,894
| New | +$798K |
|
|
AUY
844
DELISTED
Yamana Gold, Inc.
AUY
| $240K | 0.02% |
+87,100
| New | +$328K |
|
845
Dolby
DLB
$6.19B
| $239K | 0.02% |
4,400
-10,585
| -71% | -$694K |
|
846
Sonos
SONO
$1.82B
| $239K | 0.02% |
+28,200
| New | +$348K |
|
|
MSGN
847
DELISTED
MSG Networks Inc.
MSGN
| $239K | 0.02% |
23,400
+10,566
| +82% | +$151K |
|
848
Cheesecake Factory
CAKE
$5.7B
| $237K | 0.01% |
13,900
+5,651
| +69% | +$190K |
|
|
RDS.B
849
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $237K | 0.01% |
+7,246
| New | +$340K |
|
|
MRSN
850
DELISTED
Mersana Therapeutics
MRSN
| $236K | 0.01% |
1,620
+1,200
| +286% | +$210K |
|
Similar funds
Steve Schonfeld's Q1 2020 Portfolio in Review
As of Q1 2020, Steve Schonfeld held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.
- Steve Schonfeld's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
- Steve Schonfeld added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
- Steve Schonfeld's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
- Steve Schonfeld fully exited Vistra in Q1 2020, selling an estimated $89.7M.
- Steve Schonfeld's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
- Steve Schonfeld opened 455 new positions and closed 624 in Q1 2020.
- Steve Schonfeld's portfolio value fell 61% quarter-over-quarter to $1.59B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.